Predictors of Mortality and Hospitalization for Cardiac Causes in Patients with Heart Failure and Nonischemic Heart Disease: A Subanalysis of the ALPHA Study

Background: Several studies have searched for predictors of clinical outcome in patients with heart failure (HF). However, since they were collected in clinical trials, most data were subject to selection biases and do not specifically apply to patients with nonischemic heart disease. This study exa...

Full description

Saved in:
Bibliographic Details
Published inPacing and clinical electrophysiology Vol. 32; no. s1; pp. S214 - S218
Main Authors ANSELMINO, MATTEO, DE FERRARI, GAETANO M., MASSA, RICCARDO, MANCA, LORENZO, TRITTO, MASSIMO, MOLON, GIULIO, CURNIS, ANTONIO, DEVECCHI, PAOLO, BRAGA, SIMONA SARZI, BARTESAGHI, GIORGIO, KLERSY, CATHERINE, ACCARDI, FRANCESCO, SALERNO-URIARTE, JORGE A.
Format Journal Article
LanguageEnglish
Published Malden, USA Blackwell Publishing Inc 01.03.2009
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background: Several studies have searched for predictors of clinical outcome in patients with heart failure (HF). However, since they were collected in clinical trials, most data were subject to selection biases and do not specifically apply to patients with nonischemic heart disease. This study examined the impact of several variables on combined all‐cause mortality and hospitalization for cardiac causes, in consecutive ambulatory patients with HF included in the ALPHA registry. Methods and Results: This analysis included 446 patients with HF and nonischemic heart disease, in New York Heart Association functional class II or III, and a left ventricular (LV) ejection fraction below 40%. In 126 patients (73%) the disease was idiopathic dilated cardiomyopathy, in 72 (16%) hypertensive, in nine (2%) valvular, and in 39 (9%) of other etiologies. The median age was 61 years (range 51–69 years) and 349 (78%) patients were men. Over a median follow‐up of 31 months (range 23–40), 82 patients (18%) died or were hospitalized for cardiac causes. In a proportional hazard (Cox) regression model, maximal oxygen consumption (HR 0.9, P = 0.001), LV end‐diastolic diameter (HR 1.07, P < 0.001), resting systolic blood pressure (HR 0.97, P < 0.005), and hemoglobin (HR 0.86, P < 0.05) were independent predictors of the combined study endpoint. Conclusions: In an unselected population of patients with HF and nonischemic heart disease, a reduced exercise capacity, large LV end‐diastolic diameter, low systolic blood pressure, and hemoglobin were correlated with long‐term all‐cause mortality or hospitalization for cardiac causes. These observations may help stratifying and tailoring the treatment of patients with HF and nonischemic heart disease.
Bibliography:ArticleID:PACE2286
ark:/67375/WNG-32RPFB8B-K
istex:30661FE51A67C133B7C677DBDF34B990EBEB13B3
Conflicts of interest: None stated.
Funding: None reported.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0147-8389
1540-8159
DOI:10.1111/j.1540-8159.2008.02286.x